Breast Cancer Liquid Biopsy Market to Expand at 19.86% CAGR, Surpassing USD 1.67 Billion by 2030

𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐑𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟏.𝟔𝟕 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟎

The global breast cancer liquid biopsy market, valued at USD 470.26 million in 2023, is anticipated to grow at a compound annual growth rate (CAGR) of 19.86%, reaching approximately USD 1.67 billion by 2030.

𝐁𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐥𝐢𝐪𝐮𝐢𝐝 𝐛𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

Liquid biopsy is a non-invasive diagnostic technique that analyzes biomarkers such as circulating tumor cells (CTCs) and cell-free DNA (cfDNA) present in the bloodstream. This method offers a less intrusive alternative to traditional tissue biopsies, providing real-time insights into tumor genetics and aiding in personalized treatment strategies for breast cancer patients.

𝐁𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐥𝐢𝐪𝐮𝐢𝐝 𝐛𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

𝐁𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐥𝐢𝐪𝐮𝐢𝐝 𝐛𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐕𝐢𝐞𝐭𝐧𝐚𝐦 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬

Vietnam is witnessing an increasing prevalence of breast cancer, leading to a growing demand for advanced diagnostic tools. The adoption of liquid biopsy techniques presents significant opportunities to enhance early detection and treatment monitoring in the region.

𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐝𝐞𝐭𝐚𝐢𝐥𝐬 𝐚𝐧𝐝 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐫𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐨𝐫 𝐢𝐧𝐪𝐮𝐢𝐫𝐞 𝐭𝐨𝐝𝐚𝐲 : https://www.maximizemarketresearch.com/request-sample/12622/

𝐁𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐥𝐢𝐪𝐮𝐢𝐝 𝐛𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐂𝐡𝐢𝐧𝐚 𝐆𝐫𝐨𝐰𝐭𝐡

China's expanding healthcare infrastructure and emphasis on precision medicine are driving the growth of the liquid biopsy market. Government initiatives to integrate advanced diagnostics into the healthcare system support this upward trend.

𝐁𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐥𝐢𝐪𝐮𝐢𝐝 𝐛𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐡𝐚𝐢𝐥𝐚𝐧𝐝 𝐓𝐫𝐞𝐧𝐝𝐬

In Thailand, the rising awareness of breast cancer and the importance of early detection are influencing the adoption of liquid biopsy technologies. Collaborations between public health agencies and private entities are fostering market growth.

𝐁𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐥𝐢𝐪𝐮𝐢𝐝 𝐛𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐉𝐚𝐩𝐚𝐧 𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧

Japan's mature healthcare market is experiencing consolidation, with key players focusing on mergers and acquisitions to strengthen their positions in the liquid biopsy sector. The emphasis on innovation and high-quality diagnostics propels market expansion.

𝐁𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐥𝐢𝐪𝐮𝐢𝐝 𝐛𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐨𝐮𝐭𝐡 𝐊𝐨𝐫𝐞𝐚 𝐔𝐩𝐝𝐚𝐭𝐢𝐨𝐧

South Korea is updating its diagnostic protocols to incorporate liquid biopsy methods, aiming to improve patient outcomes through early and accurate detection of breast cancer. Government support for technological advancements facilitates this integration.

𝐁𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐥𝐢𝐪𝐮𝐢𝐝 𝐛𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐧𝐠𝐚𝐩𝐨𝐫𝐞 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬

Singapore's commitment to becoming a medical hub presents opportunities for the adoption of cutting-edge diagnostic tools like liquid biopsy. The country's focus on research and development in oncology diagnostics supports market growth.

𝐁𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐥𝐢𝐪𝐮𝐢𝐝 𝐛𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐔𝐧𝐢𝐭𝐞𝐝 𝐒𝐭𝐚𝐭𝐞𝐬 𝐆𝐫𝐨𝐰𝐭𝐡

The United States is experiencing significant growth in the liquid biopsy market due to increasing investments in cancer research and a strong emphasis on personalized medicine. Public-private partnerships are accelerating the development and adoption of liquid biopsy technologies.

𝐁𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐥𝐢𝐪𝐮𝐢𝐝 𝐛𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐄𝐮𝐫𝐨𝐩𝐞 𝐓𝐫𝐞𝐧𝐝𝐬

Europe is at the forefront of integrating liquid biopsy into clinical practice, driven by stringent regulatory frameworks and a focus on improving cancer diagnostics. Collaborative efforts across countries enhance the market landscape.

𝐊𝐞𝐲 𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

Guardant Health announced a strategic partnership with AstraZeneca to develop liquid biopsy companion diagnostics, aiming to advance personalized treatment options for breast cancer patients.
Biocept, Inc. expanded its portfolio by launching a new liquid biopsy test specifically designed for detecting HER2-positive breast cancer, enhancing the precision of targeted therapies.
𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐝𝐞𝐭𝐚𝐢𝐥𝐬 𝐚𝐧𝐝 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐫𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐨𝐫 𝐢𝐧𝐪𝐮𝐢𝐫𝐞 𝐭𝐨𝐝𝐚𝐲 :https://www.maximizemarketresearch.com/request-sample/12622/ 

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐤𝐞𝐲 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 :

𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞

Kits and Consumables
Instruments

𝐁𝐲 𝐂𝐢𝐫𝐜𝐮𝐥𝐚𝐭𝐢𝐧𝐠 𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫

Circulating Tumor Cells (CTCs)
Circulating Cell-free DNA (cfDNA)
Extracellular Vesicles (EVs)
Others Circulating Biomarker

𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Diagnostics

Prognostics
Risk assessment

The circulating cell-free DNA (cfDNA) segment held the biggest market share for breast cancer liquid biopsies based on application, and it is anticipated to continue to do so for the duration of the projected period. A readily available and non-invasive source of genetic material for identifying mutations linked to cancer is circulating cell-free DNA (cfDNA). Furthermore, apoptosis or cell death releases cfDNA into the circulation, which offers a dynamic and real-time representation of the genetic profile of the tumor. Additionally, because cfDNA circulates, it is possible to continuously track the course of cancer and the effectiveness of treatment, providing a long-term view of the condition. For physicians to make well-informed decisions about individualized treatment plans and modifications, this is essential.

𝐁𝐲 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫

Reference Laboratories

Hospitals and Physician Laboratories
Others

Since they are the main locations of care for patients receiving breast cancer diagnosis, treatment, and monitoring, hospitals and physician laboratories led the breast cancer liquid biopsy market in terms of revenue, according to end users. Patients seeking cancer-related services can easily access these facilities since they frequently have well-established infrastructure, including trained medical staff, diagnostic tools, and laboratory facilities. Furthermore, a variety of medical treatments, including liquid biopsy testing, can be performed in hospitals and physician labs in the same location where patients receive other care. By streamlining the diagnostic procedure, this integration makes it possible to effectively coordinate the many phases of patient care, from initial screening to treatment planning and follow-up evaluations. Furthermore, the existence of interdisciplinary teams made up of

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐝𝐚𝐭𝐚 𝐚𝐧𝐝 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐛𝐲 𝐯𝐢𝐞𝐰𝐢𝐧𝐠 𝐭𝐡𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 : @https://www.maximizemarketresearch.com/market-report/breast-cancer-liquid-biopsy-market/12622/

𝐋𝐞𝐚𝐫𝐧 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐭𝐨𝐩 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 :

1. F. Hoffmann-La Roche Ltd (Switzerland)
2. QIAGEN (Germany)
3. Biocept Inc (United States)
4. Menarini Group (Italy)
5. Guardant Health AMEA (United States)
6. Fluxion Biosciences Inc (United States)
7. Thermo Fisher Scientific Inc. (United States)
8. Neogenomics Laboratories, Inc. (United States)
9. Myriad Genetics, Inc. (United States)
10. ANGLE plc (United Kingdom)
11. Epic Sciences (United States)
12. Illumina, Inc. (United States)

𝐆𝐞𝐭 𝐚𝐧𝐬𝐰𝐞𝐫𝐬 𝐭𝐨 𝐜𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐬𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 :

What is Breast Cancer Liquid Biopsy ?
What is the growth rate of the Breast Cancer Liquid Biopsy Market?
Which are the factors expected to drive the Breast Cancer Liquid Biopsy market growth?
What is the CAGR at which the Breast Cancer Liquid Biopsy market will grow during the forecast period?
What are the different segments of the Breast Cancer Liquid Biopsy Market?
Which is the fastest growing region in the Breast Cancer Liquid Biopsy market?
What growth strategies are the players considering to increase their presence in Breast Cancer Liquid Biopsy ?
What are the upcoming opportunities and trends for the Breast Cancer Liquid Biopsy Market?
What are the recent industry trends that can be implemented to generate additional revenue streams for the Breast Cancer Liquid Biopsy Market?
Who are the leading companies and what are their portfolios in Breast Cancer Liquid Biopsy Market?
What segments are covered in the Breast Cancer Liquid Biopsy Market?
Who are the key players in the Breast Cancer Liquid Biopsy market?

𝐆𝐚𝐢𝐧 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐯𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐭𝐡𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐥𝐢𝐧𝐤 @https://www.maximizemarketresearch.com/request-sample/12622/

𝐆𝐞𝐭 𝐚 𝐜𝐥𝐨𝐬𝐞𝐫 𝐥𝐨𝐨𝐤 𝐚𝐭 𝐭𝐡𝐞 𝐠𝐚𝐦𝐞-𝐜𝐡𝐚𝐧𝐠𝐢𝐧𝐠 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐬𝐮𝐜𝐜𝐞𝐬𝐬.

Past Size and Competitive Landscape
• Past Pricing and price curve by region
• Size, Share, Size Forecast by different segment
• Dynamics Growth Drivers, Restraints, Opportunities, and Key Trends by Region
• Segmentation A detailed analysis by segment with their sub-segments and Region
• Competitive Landscape Profiles of selected key players by region from a strategic perspective

𝐂𝐡𝐞𝐜𝐤 𝐨𝐮𝐭 𝐨𝐮𝐫 𝐭𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐬𝐭𝐮𝐝𝐢𝐞𝐬 𝐭𝐨 𝐮𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐬𝐡𝐢𝐟𝐭𝐬 :

♦ Global Cast Iron Cookware Market https://www.maximizemarketresearch.com/market-report/global-cast-iron-cookware-market/22438/

♦ India Dishwashers Market https://www.maximizemarketresearch.com/market-report/india-dishwashers-market/22507/

♦ Government and Education Logistics Market https://www.maximizemarketresearch.com/market-report/government-and-education-logistics-market/198727/

♦ Cake Flour Market https://www.maximizemarketresearch.com/market-report/global-cake-flour-market/101879/

♦ India Automotive Stamping Market https://www.maximizemarketresearch.com/market-report/india-automotive-stamping-market/31488/

♦ Global Separable Connector Market https://www.maximizemarketresearch.com/market-report/global-separable-connector-market/34281/

♦ Global Pseudocapacitor Market https://www.maximizemarketresearch.com/market-report/global-pseudocapacitor-market/69846/

♦ Global GaN-based Power Supply Adapter Market https://www.maximizemarketresearch.com/market-report/global-gan-based-power-supply-adapter-market/116106/

♦ Global Transmission Electron Microscopy Market https://www.maximizemarketresearch.com/market-report/global-transmission-electron-microscopy-market/73820/

♦ Global Trench Gate Power MOSFET Market https://www.maximizemarketresearch.com/market-report/global-trench-gate-power-mosfet-market/89685/

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

𝐑𝐞𝐚𝐜𝐡 𝐎𝐮𝐭 𝐭𝐨 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐟𝐨𝐫 𝐈𝐧-𝐃𝐞𝐩𝐭𝐡 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 :

MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
sales@maximizemarketresearch.com
www.maximizemarketresearch.com

This release was published on openPR.